Pmv Pharmaceuticals Inc (PMVP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $89.89M
Last updated: Nov 17, 2026 at 4:10 PM ET
Pmv Pharmaceuticals Inc (PMVP) Stock Chart
Pmv Pharmaceuticals (PMVP) has a latest price of $1.22 on Nov 17, 2026, 36.1% below its 52-week high of $1.91. Its price fell 11.6% over the past 12 months. The month-end price fell 94.5% over the 5 years through Oct 2026, a compound annual decline of 43.9%.
Price Chart
From Sep 2020 to Oct 2026, its highest month-end close was $61.51 in Dec 2020 and its lowest $0.88 in May 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PMVP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PMVP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 4.7%, and over 6 months it fell 6.9%. The month-end price fell 13.2% over the 3 years through Oct 2026, a compound annual decline of 4.6%.
| Period | Change |
|---|---|
| 1 month | -2.8% |
| 3 months | -4.7% |
| 6 months | -6.9% |
| 12 months | -11.6% |
| 12 months, with dividends | -11.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -13.2% | -4.6% |
| 5 years | -94.5% | -43.9% |
Price by Year
Its best calendar year was 2025, when the price fell 17.2%, and its weakest was 2023, when it fell 64.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.31 | +4.8% |
| 2025 | $1.25 | -17.2% |
| 2024 | $1.51 | -51.3% |
| 2023 | $3.10 | -64.4% |
| 2022 | $8.70 | -62.3% |
| 2021 | $23.10 | -62.4% |
Trading Range
The price is 11.7% below its 50-day average of $1.38 and 6.8% below its 200-day average of $1.31.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.22 | |
| 52-week high | $1.91 | -36.1% |
| 52-week low | $1.02 | +19.6% |
| 50-day average | $1.38 | -11.7% |
| 200-day average | $1.31 | -6.8% |
Price Risk
Over 3 years, its largest fall from a peak was 74.3%.
| Measure | Value |
|---|---|
| 1-year beta | 0.71 |
| Largest fall, 1 year | -41.7% |
| Largest fall, 3 years | -74.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PMVP
What is PMVP's 1-year price change?
Pmv Pharmaceuticals's price fell 11.6% over the past 12 months. With dividends included, the 12-month total return was -11.6%.
What is PMVP's 5-year price change?
Pmv Pharmaceuticals's month-end price fell 94.5% over the 5 years through Oct 2026, a compound annual decline of 43.9%. These figures leave out dividends.
What is PMVP's 52-week high and low?
Pmv Pharmaceuticals's 52-week high is $1.91 and its 52-week low is $1.02. Its latest price of $1.22 on Nov 17, 2026 is 36.1% below the high.
What is PMVP's beta?
Pmv Pharmaceuticals's 1-year beta against the S&P 500 is 0.71, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 41.7%.
Is the PMVP chart free?
Yes. Advanced Charting for PMVP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PMVP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors